Australian Coroner Calls for TGA Review of Unapproved Peptides Following Actor Richard Norton’s Death
· GlobeWire Daily World Desk · Source: www.theguardian.com

Image: the Guardian · Photo source · Resized and letterboxed to 16:9; no AI generation
A Victorian coroner has recommended that Australia's Therapeutic Goods Administration (TGA) review unapproved peptides following the March 2025 death of actor, stuntman, and fight choreographer Richard Norton. Norton, 75, suffered a cardiac arrest after injecting prescribed doses of the unapproved peptides CJC1295 and ipamorelin. The findings, handed down on Wednesday by Victorian coroner David Ryan, suggest moving these substances from schedule 4 prescription-only drugs to schedule 10 to restrict their use solely to clinical trials or experimental settings.
Coroner's Findings and Medical Background
According to the coroner's report, Norton approached medical practitioner Dr Jerzy Muchnicki in March 2025 regarding peptide therapy for fatigue, shoulder pain, and loss of muscle mass. The report notes that Norton discussed the experimental nature of the treatment, potential risks, and lack of TGA-approved alternatives with the doctor before signing an informed consent form.
Key details from the report include:
- Prescription Date: Norton was prescribed CJC1295 and ipamorelin injections on 19 March 2025.
- Dosage Disclosure: On 28 March, Norton informed a nurse that he had been administering double the prescribed doses. A nurse advised him to return to the prescribed amount.
- Incident and Hospitalization: Hours after injecting the peptides on 28 March, Norton felt hot and flushed, became unresponsive, and died at the Alfred hospital on 30 March 2025.
Regulatory and Medical Board Responses
The Medical Board of Australia investigated Dr Muchnicki. An independent expert found insufficient evidence regarding the safety or effectiveness of CJC1295 and ipamorelin and criticized the doctor's record-keeping as inadequate. While regulatory action was not pursued, the board required Dr Muchnicki to complete one-on-one training for clinical record keeping and management, and the doctor agreed to cease prescribing peptides without robust clinical evidence.
Coroner Ryan stated that he is not satisfied such substances should remain available for prescription by medical practitioners due to acknowledged uncertainties regarding their therapeutic benefits and risks. The TGA has previously issued warnings regarding the risks associated with importing and using unapproved peptides promoted online for purposes such as weight loss, muscle growth, and anti-ageing.
Practical Implications and Verification
Readers interested in verifying regulatory announcements or safety warnings can consult official publications from the Therapeutic Goods Administration (TGA) or court findings published by the Coroners Court of Victoria.
AI-assisted reporting; source claims are attributed and have not been independently verified.



